Novacyt Sa Stock Price To Earnings To Growth
| NVYTF Stock | USD 0.64 0.06 8.57% |
Novacyt SA fundamentals help investors to digest information that contributes to Novacyt SA's financial success or failures. It also enables traders to predict the movement of Novacyt Pink Sheet. The fundamental analysis module provides a way to measure Novacyt SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novacyt SA pink sheet.
Novacyt |
Novacyt SA Company Price To Earnings To Growth Analysis
Novacyt SA's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Novacyt SA has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Novacyt Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novacyt SA's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Novacyt SA could also be used in its relative valuation, which is a method of valuing Novacyt SA by comparing valuation metrics of similar companies.Novacyt SA is currently under evaluation in price to earnings to growth category among its peers.
Novacyt Fundamentals
| Return On Equity | -0.0198 | |||
| Return On Asset | 0.0145 | |||
| Profit Margin | (0.1) % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | (50.49 M) | |||
| Shares Outstanding | 70.63 M | |||
| Shares Owned By Insiders | 3.49 % | |||
| Shares Owned By Institutions | 1.60 % | |||
| Price To Earning | 0.51 X | |||
| Price To Book | 0.40 X | |||
| Price To Sales | 1.04 X | |||
| Revenue | 95.78 M | |||
| Gross Profit | 64.87 M | |||
| EBITDA | (1.71 M) | |||
| Net Income | (9.73 M) | |||
| Cash And Equivalents | 99.65 M | |||
| Cash Per Share | 1.41 X | |||
| Total Debt | 1.67 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 4.66 X | |||
| Book Value Per Share | 1.88 X | |||
| Cash Flow From Operations | 15.69 M | |||
| Earnings Per Share | (0.17) X | |||
| Number Of Employees | 210 | |||
| Beta | -2.16 | |||
| Market Capitalization | 83.34 M | |||
| Total Asset | 183.7 M | |||
| Z Score | 29.4 | |||
| Net Asset | 183.7 M |
About Novacyt SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novacyt SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novacyt SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novacyt SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Novacyt Pink Sheet
Novacyt SA financial ratios help investors to determine whether Novacyt Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novacyt with respect to the benefits of owning Novacyt SA security.